ANGELA BURNS: Open Payments
NPI 1992339279 · BELLEVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,091 in 47 payments from 15 companies in 2025. Trend: 2023 $796 · 2024 $954 · 2025 $1,091
Food & beverage: $1,091
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $480 |
| Lilly USA, LLC | 6 | $115 |
| Novo Nordisk Inc | 4 | $77 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $71 |
| Axsome Therapeutics, Inc. | 2 | $59 |
| ABBVIE INC. | 3 | $58 |
| Amgen Inc. | 3 | $53 |
| PFIZER INC. | 2 | $31 |
| Lundbeck LLC | 1 | $27 |
| Hologic Sales and Service, LLC | 1 | $25 |
Products named: AIRSUPRA, FARXIGA, MOUNJARO, CAPLYTA, BREZTRI, Auvelity, OTEZLA, VRAYLAR.
Industry payments across IL — which companies pay providers there.
